Multicenter Study of Factors Associated with Visual and Anatomic Outcomes of Suprachoroidal Hemorrhage.

Document Type

Article

Publication Date

9-5-2025

Publication Title

Retina (Philadelphia, Pa.)

Abstract

PURPOSE: To report outcomes of suprachoroidal hemorrhage (SCH).

METHODS: Retrospective non-randomized study of eyes with SCH from two sites (1/1/2013-12/31/2022). The primary outcome was the 6-month change in visual acuity (VA). Multivariable analysis was performed, as well as a comparison of matched eyes with and without systemic steroids.

RESULTS: 143 eyes of 143 patients (mean age 70.8 years, 52.4% male) were included, with 72 perioperative, 24 traumatic, and 47 spontaneous SCH cases. The mean (SD) presenting VA was 2.07 (0.92) logMAR. 87 (60.8%) were managed non-surgically, 24 (16.8%) underwent drainage, and 32 (22.4%) underwent drainage and vitrectomy; 36 (25.2%) received systemic steroids. At 6 months, the mean (SD) change in VA from presentation was -0.41 (0.84) logMAR. 102 (71.3%) eyes achieved anatomic success (complete retinal attachment). Concurrent RD was associated with worse VA change and anatomic success in multivariable analysis (P < 0.05). In the matching analysis, eyes receiving systemic steroids were more likely to achieve ≥ 3-line gain in VA than matched eyes without systemic steroids (77.8% vs 55.3%, P = 0.047).

CONCLUSION: The visual prognosis of eyes with SCH remains guarded. Systemic steroids may be associated with a modest benefit for visual outcomes. Concurrent RD portends worse outcomes.

DOI

10.1097/IAE.0000000000004670

ISSN

1539-2864

PubMed ID

40924986

Link to Full Text

Share

COinS